Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage
of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their
governing guidelines.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Amlodipine Amlodipine, atorvastatin drug combination Atorvastatin Atorvastatin Calcium